Noncompliance with prescribed medication has been associated with increased chance of relapse and poor outcome. Side effects may be an important cause of noncompliance. Fifty-one parents of children with acute lymphoblastic leukemia in a tertiary care hospital in Indonesia were interviewed about their perception of side effects and their impact on treatment noncompliance and daily activities. A symptom checklist assessing 13 common symptoms was used to examine side effects. During chemotherapy, childhood acute lymphoblastic leukemia patients suffered from psychological as well as physical side effects. The most frequent side effect reported by parents was behavior alteration (92%). Second and third in frequency were increased appetite and infections, reported by 88% and 83% of parents, respectively. The most severe side effects were leg weakness, increased appetite, and behavior alteration. The overall frequency of side effects was weakly correlated to noncompliance. Reducing the impact of side effects may increase compliance with the treatment.
Barrera, M., Shaw, A.K., Speechley, K.N., Maunsell, E., & Pogany, L. ( 2005). Educational and social late effects of childhood cancer and related clinical, personal, and familial characteristics. Cancer, 104, 1751-1760.
2.
Bay, A., Oner, A.F., Etlik, O., Yilmaz, C., & Caksen, H. ( 2005). Myelopathy due to intrathecal chemotherapy: Report of six cases. Journal of Pediatric Hematology/Oncology, 27, 270-272.
3.
Bostrom, B.C., Sensel, M.R., Sather, H.N., Gaynon, P.S., La, M.K., Johnston, K., et al. (2003). Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: A report from the Children’s Cancer Group . Blood, 101, 3809-3817.
4.
Buizer, A.I., de Sonneville, L.M., van den Heuvel-Eibrink, M.M., & Veerman, A.J. ( 2006). Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilm’s tumor. Cancer, 106, 2067-2075.
5.
Carelle, N., Piotto, E., Bellanger, A., Germanaud, J., Thuillier, A., & Khayat, D. ( 2002). Changing patient perceptions of the side-effects of cancer chemotherapy. Cancer, 95, 155-163.
6.
Collins, J.J., Byrnes, M.E., Dunkel, I.J., Lapin, J., Nadel, T., Thaler, H.T., et al. (2000). The measurement of symptoms in children with cancer. Journal of Pain and Symptom Management, 19, 363-377.
7.
Davies, H.A., & Lilleyman, J.S. (1995). Compliance with oral chemotherapy in childhood lymphoblastic leukaemia. Cancer Treatment Reviews , 21, 93-103.
8.
Didi, M., Didcock, E., Davies, H.A., Ogilvy-Stuart, A.L., Wales, J.K., & Shalet, S.M. ( 1995). High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. Journal of Pediatrics , 127, 63-67.
9.
Eiser, C., Davies, H., Jenney, M., Stride, C., & Glaser, A. ( 2006). HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer, 46, 35-39.
10.
Hochhauser, C.J., Lewis, M., Kamen, B.A., & Cole, P.D. ( 2005). Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia. Supportive Care in Cancer, 13, 967-974.
11.
Howard, S.C., Pedrosa, M., Lins, M., Pedrosa, A., Pui, C.H., Ribeiro, R.C., et al. (2004). Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. Journal of the American Medical Association, 291, 2471-2475.
12.
Jalmsell, L., Kreicbergs, U., Onelov, E., Steineck, G., & Henter, J.I. ( 2006). Symptoms affecting children with malignancies during the last month of life: A nationwide follow-up. Pediatrics , 117, 1314-1320.
13.
Lancaster, D., Lennard, L., & Lilleyman, J.S. (1997). Profile of non-compliance in lymphoblastic leukaemia. Archives of Disease in Childhood , 76, 365-366.
14.
Magrath, I., Shanta, V., Advani, S., Adde, M., Arya, L.S., Banavali, S., et al. (2005). Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. European Journal of Cancer , 41, 1570-1583.
15.
Martin, A.R., Pearson, J.D., Cai, B., Elmer, M., Horgan, K., & Lindley, C. ( 2003). Assessing the impact of chemotherapy-induced nausea and vomiting on patients’ daily lives: A modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall. Supportive Care in Cancer, 11, 522-527.
16.
McGrath, P., & Pitcher, L. ( 2002). "Enough is enough": Qualitative findings on the impact of dexamethasone during reinduction/ consolidation for paediatric acute lymphoblastic leukaemia. Supportive Care in Cancer, 10, 146-155.
17.
Metzger, M.L., Howard, S.C., Fu, L.C., Pena, A., Stefan, R., Hancock, M.L., et al. (2003). Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet, 362, 706-708.
18.
Mitchell, C.D., Richards, S.M., Kinsey, S.E., Lilleyman, J., Vora, A., & Eden, T.O. ( 2005). Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: Results of the UK Medical Research Council ALL97 randomized trial. British Journal of Haematology , 129, 734-745.
19.
Mostert, S., Sitaresmi, M.N., Gundy, C., Sutaryo, V.A., & Veerman, A.J. ( 2006). Influence of socio-economic status of childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics , 116, e1600-e1606.
20.
Ness, K.K., Mertens, A.C., Hudson, M.M., Wall, M.M., Leisenring, W.M., Oeffinger, K.C., et al. (2005). Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Annals of Internal Medicine, 143, 639-647.
21.
Oliveira, B.M., Viana, M.B., Arruda, L.M., Ybarra, M.I., & Romanha, A.J. ( 2005). Evaluation of compliance through specific interviews: A prospective study of 73 children with acute lymphoblastic leukemia. Jornal de Pediatria, 81, 245-250.
22.
Osterberg, L., & Blaschke, T. ( 2005). Adherence to medication. New England Journal of Medicine, 353, 487-497.
23.
Partridge, A.H., Avorn, J., Wang, P.S., & Winer, E.P. ( 2002). Adherence to therapy with oral antineoplastic agents . Journal of the National Cancer Institute, 94, 652-661.
24.
Powell, J.E., Mendez, E., Parkes, S.E., & Mann, J.R. ( 2000). Factors affecting survival in White and Asian children with acute lymphoblastic leukaemia. British Journal ofCancer , 82, 1568-1570.
25.
Reilly, J.J., Brougham, M., Montgomery, C., Richardson, F., Kelly, A., & Gibson, B.E. ( 2001). Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. Journal of Clinical Endocrinology and Metabolism, 86, 3742-3745.
26.
Reilly, J.J., Ventham, J.C., Ralston, J.M., Donaldson, M., & Gibson, B. ( 1998). Reduced energy expenditure in preobese children treated for acute lymphoblastic leukemia. Pediatric Research, 44, 557-562.
27.
Ribeiro, R.C. & Pui, C.H. ( 2005). Saving the children-improving childhood cancer treatment in developing countries. New England Journal of Medicine, 352, 2158-2160.
28.
Roca, B., Gomez, C.J., & Arnedo, A. ( 2000). Adherence, side-effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients . Journal of Infection, 41, 50-54.
29.
Stam, H., Grootenhuis, M.A., Brons, P.P., Caron, H.N., & Last, B.F. ( 2005). Health-related quality of life in children and emotional reactions of parents following completion of cancer treatment. Pediatric Blood & Cancer, 47, 312-319.
30.
Sun, C.C., Bodurka, D.C., Weaver, C.B., Rasu, R., Wolf, J.K., Bevers, M.W., et al. (2005). Rankings and symptom assessments of side-effects from chemotherapy: insights from experienced patients with ovarian cancer . Supportive Care in Cancer, 13, 219-227.
31.
Sutaryo, Sumadiono, & Suhadi. ( 2000). The Protocol of Wijaya Kusuma Acute Lymphoblastic Leukemia of Childhood 2000. Indonesian Multicentre Study Group. Yogyakarta, Indonesia: Gadjah Mada University Press .
32.
Svavarsdottir, E.K. ( 2005). Caring for a child with cancer: A longitudinal perspective . Journal of Advanced Nursing, 50, 153-161.
33.
Tamaroff, M.H., Festa, R.S., Adesman, A.R., & Walco, G.A. ( 1992). Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. Journal of Pediatrics, 120, 812-817.
34.
Tebbi, C.K. ( 1993). Treatment compliance in childhood and adolescence. Cancer, 71, 3441-3449.
35.
Veerman, A.J., Sutaryo, & Sumadiono. (2005). Twinning: A rewarding scenario for development of oncology services in transitional countries. Pediatric Blood & Cancer, 45, 103-106.
36.
Waters, E., & Maher, E. ( 2000). Assessing quality of life. In V. Moyer & E. Elliot (Eds.), Evidence-based pediatric and child health (2nd ed., pp. 99-100). London: BMJ Books.
37.
Waters, E.B., Wake, M.A., Hesketh, K.D., Ashley, D.M., & Smibert, E. ( 2003). Health-related quality of life of children with acute lymphoblastic leukaemia: comparisons and correlations between parent and clinician reports. International Journal of Cancer, 103, 514-518.
